RxDoctor Payments Data

Rachael Bator

Family · North Royalton, OHNPI 1093201618

Payments from drug & device makers

$2,210in general payments, 2019–2025

Across 133 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$579
  • Novo Nordisk$433
  • AstraZeneca$376
  • Biohaven Pharmaceutical Holding Company Ltd.$187
  • Merck$110
  • Pfizer$98
  • plus $427 from 12 others

What the payments were for

  • Food & beverage$2,210100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,210 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$22,789
Medicare patients
87
Services billed
356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,369
Atorvastatin Calcium121$862
Levothyroxine Sodium66$774
Pantoprazole Sodium36$673
Potassium Chloride12$558
SynthroidLevothyroxine Sodium17$490
Hydroxyzine Hcl26$441
Albuterol Sulfate HfaAlbuterol Sulfate35$438
Omeprazole26$412
Lisinopril50$389
Famotidine11$369
Metoprolol Succinate29$351
Losartan Potassium43$320
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid13$285
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide11$276

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere$376$11,36918 claims
AbbVieSynthroid$579$49017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.

Other family in North Royalton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →